Non-viral precision T cell receptor replacement for personalized cell therapySusan P. Foy, James R. Heath, Stefanie Mandl et al.|Nature|2022Cited by 276
Obecabtagene autoleucel (obe-cel) for Adult Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Deep Molecular Remission May Predict Better OutcomesElias Jabbour, Claire Roddie, Jae H. Park et al.|Blood|2024Cited by 3
Deep Molecular Remission Predicts Better Clinical Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) Treated with Obecabtagene Autoleucel (obe-cel)Elias Jabbour, Claire Roddie, Jae H. Park et al.|Transplantation and Cellular Therapy|2025Cited by 2
Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11aJohn Manis, David A. Williams, David G. Justus et al.|Blood|2025Cited by 1